Anna French's most recent trade in Jasper Therapeutics Inc was a trade of 7,500 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 6, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Jasper Therapeutics Inc | Anna French | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 7,500 | 7,500 | - | - | Stock Option (right to buy) | |
| Jasper Therapeutics Inc | Anna French | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 47,000 | 47,000 | - | - | Stock Option (right to buy) | |
| Jasper Therapeutics Inc | Anna French | Director | Sale of securities on an exchange or to another person at price $ 1.48 per share. | 14 Apr 2023 | 7,000 | 23,750 | - | 1.5 | 10,360 | Voting Common Stock |
| Jasper Therapeutics Inc | Anna French | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2022 | 30,750 | 30,750 | - | 0 | Voting Common Stock | |
| Jasper Therapeutics Inc | Anna French | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2022 | 78,045 | 78,045 | - | - | Stock Option (right to buy) |